Cargando…

Ribosomal protein S11 influences glioma response to TOP2 poisons

Topoisomerase II poisons are one of the most common class of chemotherapeutics used in cancer. We and others had shown that a subset of glioblastomas (GBM), the most malignant of all primary brain tumors in adults, are responsive to TOP2 poisons. To identify genes that confer susceptibility to this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awah, Chidiebere U, Chen, Li, Bansal, Mukesh, Mahajan, Aayushi, Winter, Jan, Lad, Meeki, Warnke, Louisa, Gonzalez-Buendia, Edgar, Park, Cheol, Daniel, Zhang, Feldstein, Eric, Yu, Dou, Zannikou, Markella, Balyasnikova, Irina V., Martuscello, Regina, Konerman, Silvana, Győrffy, Balázs, Burdett, Kirsten B, Scholtens, Denise M, Stupp, Roger, Ahmed, Atique, Hsu, Patrick, Sonabend, Adam M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646677/ https://www.ncbi.nlm.nih.gov/pubmed/32528131 http://dx.doi.org/10.1038/s41388-020-1342-0

Ejemplares similares

MODL-12. DEVELOPMENT OF A NOVEL IMMUNOCOMPETENT MOUSE MODEL FOR DIFFUSE INTRINSIC PONTINE GLIOMA
por: Seblani, Maggie, et al.
Publicado: (2020)

Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas
por: Pawlowski, Kristen D., et al.
Publicado: (2023)

Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy
por: Mehta, Amol, et al.
Publicado: (2018)

Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastases
por: Procissi, Daniele, et al.
Publicado: (2022)

Protein Tyrosine Phosphatase-1B Inhibition Disrupts IL13Rα2-Promoted Invasion and Metastasis in Cancer Cells
por: Bartolomé, Rubén A., et al.
Publicado: (2020)

IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
por: Zannikou, Markella, et al.
Publicado: (2023)

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
por: Zhang, Peng, et al.
Publicado: (2023)

TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas
por: Gonzalez-Buendia, Edgar, et al.
Publicado: (2021)

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts
por: McCord, Matthew, et al.
Publicado: (2022)

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
por: Sonabend, Adam M., et al.
Publicado: (2021)

A regulatory SNP modifies cystic fibrosis by disrupting NFκB complex binding on FAS
por: Awah, Chidiebere U, et al.
Publicado: (2015)

Pituitary adenomas and cerebrovascular disease: A review on pathophysiology, prevalence, and treatment
por: Osorio, Robert C., et al.
Publicado: (2022)

Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas
por: Gould, Andrew, et al.
Publicado: (2021)

NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction
por: Awah, Chidiebere U, et al.
Publicado: (2021)

Mobile Phone Ownership, Health Apps, and Tablet Use in US Adults With a Self-Reported History of Hypertension: Cross-Sectional Study
por: Langford, Aisha T, et al.
Publicado: (2019)

B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma
por: Javier, Rodrigo, et al.
Publicado: (2018)

Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells
por: Oh, Jun Y., et al.
Publicado: (2022)

Activation of 4-1BBL(+) B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
por: Lee-Chang, Catalina, et al.
Publicado: (2020)

Therapeutic Targeting of Exportin-1 in Childhood Cancer
por: Galinski, Basia, et al.
Publicado: (2021)

The use of anti-GITR antibody treatment in a murine model of glioblastoma multiforme
por: Miska, Jason, et al.
Publicado: (2015)

Destabilized 3’UTR elements therapeutically degrade ERBB2 mRNA in drug-resistant ERBB2+ cancer models
por: Awah, Chidiebere U., et al.
Publicado: (2023)

Hepatitis C Treatment and Barriers to Eradication
por: Konerman, Monica A, et al.
Publicado: (2016)

Endoscopic Ultrasound as a Diagnostic Tool in a Case of Obscure Hemobilia
por: Konerman, Monica A., et al.
Publicado: (2016)

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
por: Arrieta, Víctor A., et al.
Publicado: (2023)

Ribosome-omics of the human ribosome
por: Gupta, Varun, et al.
Publicado: (2014)

Multi-omic screening of invasive GBM cells in engineered biomaterials and patient biopsies reveals targetable transsulfuration pathway alterations
por: Garcia, Joseph H., et al.
Publicado: (2023)

Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology
por: Kühn, Rebekka, et al.
Publicado: (2021)

Ultrasound-mediated blood–brain barrier opening increases cell-free DNA in a time-dependent manner
por: Zhang, Daniel Y, et al.
Publicado: (2021)

Imaging Advances in Colorectal Cancer
por: Balyasnikova, Svetlana, et al.
Publicado: (2016)

(Re)Introducing Vygotsky’s Thought: From Historical Overview to Contemporary Psychology
por: Vasileva, Olga, et al.
Publicado: (2019)

Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management
por: Balyasnikova, Svetlana, et al.
Publicado: (2016)

Glioma microenvironment-derived CCL2 recruits regulatory T cells and myeloid-derived suppressor cells
por: Chang, Alan L, et al.
Publicado: (2015)

Ebola Virus Diseases in Africa: a commentary on its history, local and global context
por: Awah, Paschal Kum, et al.
Publicado: (2015)

Utility of routine evaluations for rejection in patients greater than 2 years after heart transplantation
por: Golbus, Jessica R., et al.
Publicado: (2020)

LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma
por: Baisiwala, Shivani, et al.
Publicado: (2020)

Structures and Ribosomal Interaction of Ribosome-Inactivating Proteins
por: Shi, Wei-Wei, et al.
Publicado: (2016)

Ribosome Biogenesis and Cancer: Overview on Ribosomal Proteins
por: Pecoraro, Annalisa, et al.
Publicado: (2021)

Identifying ribosome heterogeneity using ribosome profiling
por: Alkan, Ferhat, et al.
Publicado: (2022)

Comparison of Clinical Characteristics and Outcome of Critically Ill Patients Admitted to Tertiary Care Intensive Care Units in India during the Peak Months of First and Second Waves of COVID-19 Pandemic: A Retrospective Analysis
por: Kerai, Sukhyanti, et al.
Publicado: (2021)

PCM1 Depletion Inhibits Glioblastoma Cell Ciliogenesis and Increases Cell Death and Sensitivity to Temozolomide()
por: Hoang-Minh, Lan B., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cu83ev6frcncn9032htcvg6fo6